Influenza, Human  >>  Inavir (laninamivir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inavir (laninamivir) / Daiichi Sankyo
NCT00311714: Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

Completed
1
40
Europe
CS-8958 formulated as dry powder, Placebo
Biota Scientific Management Pty Ltd, National Institute of Allergy and Infectious Diseases (NIAID)
Influenza
 
12/07
NCT00995826: Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958

Completed
1
16
Europe
CS-8958, Laninamivir, Placebo
Biota Scientific Management Pty Ltd, National Institute of Allergy and Infectious Diseases (NIAID)
Influenza
09/09
11/09
NCT00657111: CS-8958 Single Inhaled Dose in Elderly

Completed
1
38
Europe
CS-8958 formulated as dry powder, Placebo
Biota Scientific Management Pty Ltd, National Institute of Allergy and Infectious Diseases (NIAID)
Influenza
10/09
10/09

Download Options